Skip to content

Author

Daisuke Harada

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Safety and effectiveness of efgartigimod in patients with generalized myasthenia gravis by autoantibody subtype: analysis of post-marketing surveillance in Japan

Efgartigimod for intravenous infusion (efgartigimod-IV) is approved in Japan for generalized myasthenia gravis (gMG) regardless of autoantibody subtypes, whereas the approvals in other countries are restricted to only anti-acetylcholine receptor antibody (AChR-Ab) positive. Post-marketing surveillance was conducted...

Hirofumi Teranishi, Ryohei Aoyagi, Daisuke Harada · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.